iShares Biotechnology ETF (IBB)

Delayed Data
As of 5:34pm ET
 -2.69 / -2.13%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.


1 month-18.52% 3 years+5.06%
3 months-21.19% 5 years+7.11%
1 year-23.27% Since inception+6.72%
Data through 01/27/2022

Quote Details

Previous close$126.10
Open day’s range123.41 – 127.82
Net asset value (NAV)126.11 (01/26/2022)
Daily volume411,163
Average volume (3 months)2,343,312
Data as of 5:34pm ET, 01/27/2022

Peer Comparisonvs. Health ETFs

Performance 5-yr return+7.11%+15.55%
Expense Gross exp ratio0.45%1.01%
Risk 5 year sharpe ratio0.600.85
Net assets$10.0B$2.3B
Average market cap$20.1B$37.5B
Average P/E19.423.2
Dividend / Share--0.29%


VHT Vanguard Health Care Index Fund ETF Shar...
FHLC Fidelity MSCI Health Care Index ETF
RYH Invesco S&P 500® Equal Weight Health Ca...


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
AMGN Amgen9.13%
GILD Gilead Sciences7.13%
MRNA Moderna Inc5.82%
REGN Regeneron Pharmaceuticals5.08%
VRTX Vertex Pharmaceuticals Inc4.35%
ILMN Illumina Inc4.20%
IQV IQVIA Holdings Inc4.18%
BNTX BioNTech SE3.13%
MTD Mettler-Toledo International Inc3.01%
BIIB Biogen2.75%